Literature DB >> 30404006

Genetic Models Reveal cis and trans Immune-Regulatory Activities for lincRNA-Cox2.

Roland Elling1, Elektra K Robinson2, Barbara Shapleigh2, Stephen C Liapis3, Sergio Covarrubias2, Sol Katzman4, Abigail F Groff3, Zhaozhao Jiang5, Shiuli Agarwal5, Mona Motwani5, Jennie Chan5, Shruti Sharma5, Elizabeth J Hennessy6, Garret A FitzGerald6, Michael T McManus7, John L Rinn8, Katherine A Fitzgerald5, Susan Carpenter9.   

Abstract

An inducible gene expression program is a hallmark of the host inflammatory response. Recently, long intergenic non-coding RNAs (lincRNAs) have been shown to regulate the magnitude, duration, and resolution of these responses. Among these is lincRNA-Cox2, a dynamically regulated gene that broadly controls immune gene expression. To evaluate the in vivo functions of this lincRNA, we characterized multiple models of lincRNA-Cox2-deficient mice. LincRNA-Cox2-deficient macrophages and murine tissues had altered expression of inflammatory genes. Transcriptomic studies from various tissues revealed that deletion of the lincRNA-Cox2 locus also strongly impaired the basal and inducible expression of the neighboring gene prostaglandin-endoperoxide synthase (Ptgs2), encoding cyclooxygenase-2, a key enzyme in the prostaglandin biosynthesis pathway. By utilizing different genetic manipulations in vitro and in vivo, we found that lincRNA-Cox2 functions through an enhancer RNA mechanism to regulate Ptgs2. More importantly, lincRNA-Cox2 also functions in trans, independently of Ptgs2, to regulate critical innate immune genes in vivo. Published by Elsevier Inc.

Entities:  

Keywords:  CRISPR/Cas9; CRISPRi; Ptgs2; inflammation; innate immunity; lincRNA-Cox2

Mesh:

Substances:

Year:  2018        PMID: 30404006      PMCID: PMC6291222          DOI: 10.1016/j.celrep.2018.10.027

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  58 in total

1.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

Review 2.  The X chromosome in space.

Authors:  Teddy Jégu; Eric Aeby; Jeannie T Lee
Journal:  Nat Rev Genet       Date:  2017-05-08       Impact factor: 53.242

3.  LincRNA-Cox2 modulates TNF-α-induced transcription of Il12b gene in intestinal epithelial cells through regulation of Mi-2/NuRD-mediated epigenetic histone modifications.

Authors:  Qiang Tong; Ai-Yu Gong; Xin-Tian Zhang; Chengchi Lin; Shibin Ma; Jing Chen; Guoku Hu; Xian-Ming Chen
Journal:  FASEB J       Date:  2015-11-17       Impact factor: 5.191

4.  Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function.

Authors:  Dairong Wang; Vickas V Patel; Emanuela Ricciotti; Rong Zhou; Mark D Levin; Ehre Gao; Zhou Yu; Victor A Ferrari; Min Min Lu; Junwang Xu; Hualei Zhang; Yiqun Hui; Yan Cheng; Nataliya Petrenko; Ying Yu; Garret A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-17       Impact factor: 11.205

5.  LincRNA-Cox2 Promotes Late Inflammatory Gene Transcription in Macrophages through Modulating SWI/SNF-Mediated Chromatin Remodeling.

Authors:  Guoku Hu; Ai-Yu Gong; Yang Wang; Shibin Ma; Xiqiang Chen; Jing Chen; Chun-Jen Su; Annemarie Shibata; Juliane K Strauss-Soukup; Kristen M Drescher; Xian-Ming Chen
Journal:  J Immunol       Date:  2016-02-15       Impact factor: 5.422

6.  The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse.

Authors:  Phillip Grote; Lars Wittler; David Hendrix; Frederic Koch; Sandra Währisch; Arica Beisaw; Karol Macura; Gaby Bläss; Manolis Kellis; Martin Werber; Bernhard G Herrmann
Journal:  Dev Cell       Date:  2013-01-28       Impact factor: 12.270

7.  Deep genome sequencing and variation analysis of 13 inbred mouse strains defines candidate phenotypic alleles, private variation and homozygous truncating mutations.

Authors:  Anthony G Doran; Kim Wong; Jonathan Flint; David J Adams; Kent W Hunter; Thomas M Keane
Journal:  Genome Biol       Date:  2016-08-01       Impact factor: 13.583

Review 8.  Considerations when investigating lncRNA function in vivo.

Authors:  Andrew R Bassett; Asifa Akhtar; Denise P Barlow; Adrian P Bird; Neil Brockdorff; Denis Duboule; Anne Ephrussi; Anne C Ferguson-Smith; Thomas R Gingeras; Wilfried Haerty; Douglas R Higgs; Eric A Miska; Chris P Ponting
Journal:  Elife       Date:  2014-08-14       Impact factor: 8.140

9.  The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.

Authors:  Jonathan J Kotzin; Sean P Spencer; Sam J McCright; Dinesh B Uthaya Kumar; Magalie A Collet; Walter K Mowel; Ellen N Elliott; Asli Uyar; Michelle A Makiya; Margaret C Dunagin; Christian C D Harman; Anthony T Virtue; Stella Zhu; Will Bailis; Judith Stein; Cynthia Hughes; Arjun Raj; E John Wherry; Loyal A Goff; Amy D Klion; John L Rinn; Adam Williams; Richard A Flavell; Jorge Henao-Mejia
Journal:  Nature       Date:  2016-08-15       Impact factor: 49.962

10.  The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2.

Authors:  Philipp Neumann; Nicolas Jaé; Andrea Knau; Simone F Glaser; Youssef Fouani; Oliver Rossbach; Marcus Krüger; David John; Albrecht Bindereif; Phillip Grote; Reinier A Boon; Stefanie Dimmeler
Journal:  Nat Commun       Date:  2018-01-16       Impact factor: 14.919

View more
  24 in total

1.  Noncoding RNAs in inflammation and colorectal cancer.

Authors:  Shengyun Ma; Tianyun Long; Wendy Jia Men Huang
Journal:  RNA Biol       Date:  2019-12-26       Impact factor: 4.652

2.  Classification of Long Noncoding RNAs by k-mer Content.

Authors:  Jessime M Kirk; Daniel Sprague; J Mauro Calabrese
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Long noncoding RNA loss in immune suppression in cancer.

Authors:  Qingsong Hu; Sergey D Egranov; Chunru Lin; Liuqing Yang
Journal:  Pharmacol Ther       Date:  2020-05-29       Impact factor: 12.310

Review 4.  What sequencing technologies can teach us about innate immunity.

Authors:  Mays Mohammed Salih; Susan Carpenter
Journal:  Immunol Rev       Date:  2021-11-07       Impact factor: 12.988

Review 5.  From genotype to phenotype: genetics of mammalian long non-coding RNAs in vivo.

Authors:  Daniel Andergassen; John L Rinn
Journal:  Nat Rev Genet       Date:  2021-11-26       Impact factor: 53.242

6.  The potential role of serum expression profile of long non coding RNAs, Cox2 and HOTAIR as novel diagnostic biomarkers in systemic lupus erythematosus.

Authors:  Rania H Mahmoud; Nermeen A Fouad; Enas M Hefzy; Olfat G Shaker; Tarek I Ahmed; Hoda A Hussein; Maha H Nasr; Othman M Zaki; Noha K Abdelghaffar; Omayma O Abdelaleem
Journal:  PLoS One       Date:  2022-08-16       Impact factor: 3.752

7.  LINC00892 Is an lncRNA Induced by T Cell Activation and Expressed by Follicular Lymphoma-Resident T Helper Cells.

Authors:  Ingram Iaccarino; Fatme Mourtada; Sarah Reinke; Paurnima Patil; Gero Doose; Gianni Monaco; Steve Hoffmann; Reiner Siebert; Wolfram Klapper
Journal:  Noncoding RNA       Date:  2022-06-01

Review 8.  Long Noncoding RNAs in Host-Pathogen Interactions.

Authors:  Federica Agliano; Vijay A Rathinam; Andrei E Medvedev; Sivapriya Kailasan Vanaja; Anthony T Vella
Journal:  Trends Immunol       Date:  2019-04-30       Impact factor: 16.687

9.  p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis.

Authors:  Christiane E Olivero; Elena Martínez-Terroba; Joshua Zimmer; Clara Liao; Ephrath Tesfaye; Nima Hooshdaran; Jeremy A Schofield; Jordan Bendor; Dorthy Fang; Matthew D Simon; Jesse R Zamudio; Nadya Dimitrova
Journal:  Mol Cell       Date:  2020-01-20       Impact factor: 17.970

10.  Role of lincRNA-Cox2 targeting miR-150 in regulating the viability of chondrocytes in osteoarthritis.

Authors:  Meng Jiang; Kai Xu; Huafeng Ren; Mingmin Wang; Ximin Hou; Jianping Cao
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.